Cargando…
Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells
INTRODUCTION: The emergence of SARS-CoV-2, which causes COVID-19, has led to over 400 million reported cases worldwide. COVID-19 disease ranges from asymptomatic infection to severe disease and may be impacted by individual immune differences. METHODS: We used multiparameter flow cytometry to compar...
Autores principales: | Lesteberg, Kelsey E., Araya, Paula, Waugh, Katherine A., Chauhan, Lakshmi, Espinosa, Joaquin M., Beckham, J. David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932815/ https://www.ncbi.nlm.nih.gov/pubmed/36817450 http://dx.doi.org/10.3389/fimmu.2023.1113932 |
Ejemplares similares
-
Circulating CD62E(+) Microparticles and Cardiovascular Outcomes
por: Lee, Soon-Tae, et al.
Publicado: (2012) -
Circulating ILC precursors expressing CD62L exhibit a type 2 signature distinctly decreased in psoriatic patients
por: Campana, Stefania, et al.
Publicado: (2021) -
Perforin and hematological cancer
por: Covas, Dimas Tadeu
Publicado: (2011) -
Blood Neutrophils In COPD But Not Asthma Exhibit A Primed Phenotype With Downregulated CD62L Expression
por: Lokwani, Ravi, et al.
Publicado: (2019) -
Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema
por: Morissette, Mathieu C, et al.
Publicado: (2007)